Neurology Central

Depression symptoms improved through targeting of metabolic deficiencies

Major depressive disorder is estimated to affect almost 15 million American adults, at least 15% of whom are not sufficiently treated by conventional therapies, including antidepressant medication and psychotherapy. A new study from researchers at University of Pittsburgh School of Medicine (PA, USA) provides hope for a novel approach to treating the disorder, targeting metabolic deficiencies.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.